- Waldenström Macroglobulinemia
- Melanoma
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Childhood Cancers
- Gastric Cancer
- Gynecologic Cancer
- Head & Neck Cancer
- Immunotherapy
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma Cancer
- Mesothelioma
- MPN
- MDS
- Myeloma
- Prostate Cancer
- Rare Cancers
- Sarcoma
- Skin Cancer
- Testicular Cancer
- Thyroid Cancer
Facing Challenges and Excitement for Immunotherapy in GI Cancers
The science behind immunotherapy and gastrointestinal cancers is not quite perfected yet, but one subset of patients is seeing remarkable results.
Gregory Beatty, M.D., Ph.D., assistant professor at the University of Pennsylvania Perelman School of Medicine, discusses challenges of using immunotherapy to treat gastrointestinal (GI) cancers.
The majority of the immune system is located in the gut, Beatty says, and every single day, it encounters many pathogens and has to decide to fight them or not. Because of this, it might be difficult to spark the immune system when a foreign body, like cancer, is located there.
However, there are some subsets of GI cancers whose tumors have DNA mismatch repair — which ultimately leads to microsatellite instability – that look more like an invader, thus activating the immune response. This group of patients has seen astounding results with the use of checkpoint inhibitors.
The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer
February 16th 2023Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
Listen
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Listen
